Expression of midkine and pleiotropin in ovarian tumors

Obstetrics and Gynecology

Volumn 90, Issue 2, 1997, Pages 285-290

  Nakanishi, Toru ^a   Kadomatsu, Kenji ^a   Okamoto, Tomomitsu ^a   Tomoda, Yutaka ^a   Muramatsu, Takashi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; MIDKINE; PLEIOTROPHIN; RNA DIRECTED DNA POLYMERASE;

ARTICLE; CONTROLLED STUDY; EPITHELIUM TUMOR; GENE EXPRESSION; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NORTHERN BLOTTING; OVARY CANCER; OVARY TUMOR; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

ADULT; AGED; BLOTTING, NORTHERN; CARRIER PROTEINS; CYTOKINES; FEMALE; GENE EXPRESSION; GROWTH SUBSTANCES; HUMANS; IN SITU HYBRIDIZATION; MIDDLE AGED; OVARIAN DISEASES; OVARIAN NEOPLASMS; OVARY; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0030791615     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(97)00237-8     Document Type: Article

References (20)

1. Aaronson SA. Growth factors and cancer. Science 1991;254:1146-53.
2. Heldin CH, Westermark B. Growth factors as transforming proteins. Eur J Biochem 1989;184:487-96.
3. Di BA, Carniti C, Vigano P, Vignali M. Basic fibroblast growth factor and ovarian cancer. J Steroid Biochem Mol Biol 1995;53: 375-9.
4. Boocock CA, Charnock-Jones DS, Sharkey AM, McLaren J, Barker PJ, Wright KA, et al. Expression of vascular endothelial growth factor and its receptors fit and KDR in ovarian carcinoma. J Natl Cancer Inst 1995;87:506-16.
5. Renzo MFD, Olivero M, Katsaros D, Crepaldi T, Gagilia P, Zola P, et al. Overexpression of the MET/HGF receptor in ovarian cancer. Int J Cancer 1994;58:658-62.
6. Kadomatsu K, Tomomura M, Muramatsu T. cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem Biophys Res Commun 1988;151:1312-8.
7. Li YS, Milner PG, Chauhan AK, Watson MA, Hoffman RM, Kodner CM, et al. Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science 1990;250:1690-4.
8. Muramatsu H, Muramatsu T. Purification of recombinant midkine and examination of its biological activities: Functional comparison of new heparin binding factors. Biochem Biophys Res Commun 1991;177:652-8.
9. Kojima S, Inui T, Kimura T, Sakakibara S, Muramatsu H, Amanuma H, et al. Synthetic peptides derived from midkine enhance plasminogen activator activity in bovine aortic endothelial cells. Biochem Biophys Res Commun 1995;206:468-73.
10. Kadomatsu K, Hagihara M, Akhter S, Fan QW, Muramatsu H, Muramatsu T. Midkine induces the transformation of NIH3T3 cells. Br J Cancer 1997;75:354-9.
11. Tsutsui J, Kadomatsu K, Matsubara S, Nakagawara A, Hamanoue M, Takao S, et al. A new family of heparin-binding growth/ differentiation factors: Increased midkine expression in Wilms' tumor and other human carcinomas. Cancer Res 1993;53:1281-5.
12. Garver R Jr, Radford DM, Donis-Keller H, Wick MR, Milner PG. Midkine and pleiotrophin expression in normal and malignant breast tissue. Cancer 1994;74:1584-90.
13. Garver R Jr, Chan CS, Milner PG. Reciprocal expression of pleiotrophin and midkine in normal versus malignant lung tissues. Am J Respir Cell Mol Biol 1993;9:463-6.
14. Aridome K, Tsutsui J, Takao S, Kadomatsu K, Ozawa M, Aikou T, et al. Increased midkine gene expression in human gastrointestinal cancers. Jpn J Cancer Res 1995;86:655-61.
15. O'Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL. The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers. Cancer Res 1996;56:2515-8.
16. Nakagawara A, Milbrandt J, Muramatsu T, Deuel TF, Zhao H, Cnaan A, et al. Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Res 1995;55:1792-7.
17. Kaname T, Kadomatsu K, Aridome K, Yamashita S, Sakamoto K, Ogawa M, et al. The expression of truncated MK in human tumor. Biochem Biophys Res Commun 1996;219:256-60.
18. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain terminating inhibition. Proc Natl Acad Sci USA 1977;74:5463-7.
19. Ohyama Y, Miyamoto K, Minamino N, Matsuo H. Isolation and identification of midkine and pleiotrophin in bovine follicular fluid. Mol Cell Endocrinol 1994;105:203-8.
20. Karino S, Minegishi T, Ohyama Y, Tano M, Nakamura K, Miyamoto K, et al. Regulation and localization of midkine in rat ovary. FEBS Lett 1995;362:147-50.